Top Markets
Coin of the day
IMBdx IMBdx

IMBdx

461030
Rang in aandelen #27739
IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for... IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-stage cancers, enabling the early identification of cancer recurrence after surgical interventions, and providing solutions for the early diagnosis of cancer. Its notable product offerings include AlphaLiquid, CancerDetect, and CancerFind. The firm was established by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018, and maintains its headquarters in Seoul, South Korea.
Aandeelprijs
$2.14
Marktkapitalisatie
$30.63M
Verandering (1 dag)
0.16%
Verandering (1 jaar)
-62.09%
Land
KR
Handel IMBdx (461030)

Categorie

Koersgeschiedenis voor IMBdx (461030)
Hoogste slotkoers: $2.31 op 2026-08-01

Laagste slotkoers: $14.99 op 2024-04-01
Koersgeschiedenis van IMBdx van 2024 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -26.19%
2025 -3.47%
2024 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$753.28 5.84%
CH